Carl S. Goodyear

7.5k total citations · 2 hit papers
110 papers, 4.2k citations indexed

About

Carl S. Goodyear is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Carl S. Goodyear has authored 110 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Immunology, 36 papers in Molecular Biology and 30 papers in Rheumatology. Recurrent topics in Carl S. Goodyear's work include Monoclonal and Polyclonal Antibodies Research (19 papers), T-cell and B-cell Immunology (15 papers) and Immune Cell Function and Interaction (13 papers). Carl S. Goodyear is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), T-cell and B-cell Immunology (15 papers) and Immune Cell Function and Interaction (13 papers). Carl S. Goodyear collaborates with scholars based in United Kingdom, United States and Canada. Carl S. Goodyear's co-authors include Gregg J. Silverman, Peter X. Shaw, Joseph L. Witztum, Hugh J. Willison, Mi-Kyung Chang, Christoph J. Binder, Asheesh K. Dewan, Wulf Palinski, Sohvi Hörkkö and Foo Y. Liew and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Carl S. Goodyear

103 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL

2003 590 citations Mi-Kyung Chang, Carl S. Goodyear et al. profile →
Large-vessel vasculitis

2022 127 citations Dan Pugh, Neil Basu et al. Nature Reviews Disease Primers profile →

Peers

Countries citing papers authored by Carl S. Goodyear

Since Specialization

Citations

This map shows the geographic impact of Carl S. Goodyear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl S. Goodyear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl S. Goodyear more than expected).

Fields of papers citing papers by Carl S. Goodyear

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl S. Goodyear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl S. Goodyear. The network helps show where Carl S. Goodyear may publish in the future.

Co-authorship network of co-authors of Carl S. Goodyear

This figure shows the co-authorship network connecting the top 25 collaborators of Carl S. Goodyear. A scholar is included among the top collaborators of Carl S. Goodyear based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl S. Goodyear. Carl S. Goodyear is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigating endogenous immune-mediated monocyte memory in rheumatoid arthritis 2025 ·Annals of the Rheumatic Diseases ·Anna M. Marzeda, Anja Schwenzer, (unknown), (unknown), Jean-Baptiste Richard, Linda W. Jennings, Amélie M. Julé, Nan Yang, Sarah Davidson, (unknown), Adam P. Cribbs, Calliope A. Dendrou, Wyatt W. Yue, Carl S. Goodyear, Karim Raza, Kim S. Midwood	3
2	The insula represents a key neurobiological pain hub in psoriatic arthritis 2025 ·Arthritis Research & Therapy ·Flavia Sunzini, (unknown), (unknown), Chelsea Kaplan, Andrew Schrepf, (unknown), Steven E. Harte, Richard E. Harris, Daniel J. Clauw, John McLean, Stefan Siebert, Carl S. Goodyear, Gordon D. Waiter, Neil Basu	1
3	Titanium Surface Synergy: Strontium Incorporation and Controlled Disorder Nanotopography Optimize Osteoinduction 2024 ·ACS Applied Materials & Interfaces ·Peter S. Young, (unknown), (unknown), (unknown), Penelope M. Tsimbouri, Dominic Meek, Carl S. Goodyear, Nikolaj Gadegaard, Matthew J. Dalby	2
4	Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14<sup>+</sup> Monocytes 2023 ·Journal of Visualized Experiments ·(unknown), (unknown), Carl S. Goodyear, Cecilia Ansalone	2
5	Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy 2023 ·Nature Reviews Rheumatology ·Aurélie Najm, Carl S. Goodyear, Iain B. McInnes, Stefan Siebert	17
6	Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis 2023 ·BMJ Open ·(unknown), Hussein Al‐Mossawi, (unknown), (unknown), Paul Bowness, Anne Francis, Carl S. Goodyear, Bruce Kirkham, Sylvine Lalnunhlimi, Iain B. McInnes, Duncan Richards, Stefan Siebert, Leonie S. Taams, Aysın Tulunay Virlan, Nicole Yager, Laura C. Coates	5
7	P1350: M2-LIKE MONOCYTE-DERIVED MACROPHAGES PROTECT AML CELL LINES AND PRIMARY AML CELLS AGAINST THERAPY-INDUCED APOPTOSIS 2023 ·HemaSphere ·(unknown), Αθανασία Παπαδοπούλου, Leandro Marcelo Martinez, Victoria Campbell, Carl S. Goodyear, Helen Wheadon, Mónica L. Guzmán, Mark Williams	0
8	Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritis 2023 ·Frontiers in Immunology ·(unknown), (unknown), Katherine Miles, David Gray, Carl S. Goodyear, Thomas D. Otto, S. J. Breusch, Graeme Cowan, Mohini Gray	19
9	Destabilization of the Medial Meniscus and Cartilage Scratch Murine Model of Accelerated Osteoarthritis 2022 ·Journal of Visualized Experiments ·Lynette Dunning, Kendal McCulloch, John C. Lockhart, Carl S. Goodyear, Carmen Huesa	1
10	A Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity 2022 ·Journal of Crohn s and Colitis ·Joachim Høg Mortensen, Dovilė Sinkevičiūtė, Tina Manon‐Jensen, Viktor Domislović, (unknown), Christian S. Thudium, (unknown), Patrik Önnerfjord, Carl S. Goodyear, Željko Krznarić, M.A. Karsdal, Anne‐Christine Bay‐Jensen	35
11	Large-vessel vasculitis breakdown → 2022 ·Nature Reviews Disease Primers ·Dan Pugh, (unknown), Neil Basu, María C. Cid, Ruchika Goel, Carl S. Goodyear, Peter C. Grayson, Stephen P. McAdoo, Justin C. Mason, Catherine Owen, Cornelia M. Weyand, Taryn Youngstein, Neeraj Dhaun	127
12	Searchlight: automated bulk RNA-seq exploration and visualisation using dynamically generated R scripts 2021 ·BMC Bioinformatics ·(unknown), (unknown), David McGuinness, Robin Shaw, Rose A. Maciewicz, Neil Robertson, Carl S. Goodyear	16
13	β2 Integrins differentially regulate γδ T cell subset thymic development and peripheral maintenance 2020 ·Proceedings of the National Academy of Sciences ·(unknown), Leticia Monin, (unknown), Thomas D. Otto, Carl S. Goodyear, Adrian Hayday, Vicky L. Morrison	7
14	MicroRNA‐17‐5p Reduces Inflammation and Bone Erosions in Mice With Collagen‐Induced Arthritis and Directly Targets the JAK/STAT Pathway in Rheumatoid Arthritis Fibroblast‐like Synoviocytes 2020 ·Arthritis & Rheumatology ·Aurélie Najm, (unknown), (unknown), (unknown), Benjamin Ory, Thibaut Quillard, (unknown), Carl S. Goodyear, Douglas J. Veale, Ursula Fearon, Benoît Le Goff, Frédéric Blanchard	85
15	Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis 2011 ·Journal of Neuroimmunology ·Kathryn M. Brennan, (unknown), Simon Rinaldi, Colin O’Leary, Carl S. Goodyear, Gabriela Kalna, Ariel Arthur, (unknown), Sue Barnett, Christopher Linington, Jeffrey L. Bennett, Gregory P. Owens, Hugh J. Willison	63
16	Regulation of Dendritic Cells and Macrophages by an Anti-Apoptotic Cell Natural Antibody that Suppresses TLR Responses and Inhibits Inflammatory Arthritis 2009 ·The Journal of Immunology ·Yifang Chen, Sahil Khanna, Carl S. Goodyear, Yong Beom Park, Eyal Raz, Steffen Thiel, Caroline Grönwall, Jaya Vas, David L. Boyle, Maripat Corr, Dwight H. Kono, Gregg J. Silverman	123
17	Galectin-3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis 2009 ·The Journal of Immunology ·Hui‐Rong Jiang, Zakeya Al Rasbi, E.P.K. Mensah‐Brown, Allen Shahin, Damo Xu, Carl S. Goodyear, Sandra Yasuyo Fukada, Fu‐Tong Liu, Foo Y. Liew, Miodrag L. Lukić	156
18	Cutting Edge: Bim Is Required for Superantigen-Mediated B Cell Death 2007 ·The Journal of Immunology ·Carl S. Goodyear, Maripat Corr, (unknown), David L. Boyle, Gregg J. Silverman	22
19	Temporal and Dose-Dependent Relationships between In Vivo B Cell Receptor-Targeted Proliferation and Deletion-Induced by a Microbial B Cell Toxin 2006 ·The Journal of Immunology ·Carl S. Goodyear, (unknown), Gregg J. Silverman	22
20	The Autoreactivity of Anti-Phosphorylcholine Antibodies for Atherosclerosis-Associated Neo-Antigens and Apoptotic Cells 2003 ·The Journal of Immunology ·Peter X. Shaw, Carl S. Goodyear, Mi-Kyung Chang, Joseph L. Witztum, Gregg J. Silverman	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact